Determination of leucovorin and 5-fluorouracil in plasma by high-performance liquid chromatography. 1993

C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
Department of Pharmaceutical and Biomedical Analysis, Vrije Universiteit Brussel, Belgium.

A method was developed for the determination of (6R)- and (6S)-leucovorin and 5-fluorouracil in plasma. As leucovorin diastereoisomers cannot be separated on a classical reversed-phase column, it was necessary to use a chiral stationary phase. The method presented is based on the same principle as the method described by Wainer and Stiffin [J. Chromatogr., 424 (1988) 158], i.e., coupling of a bovine serum albumin phase to an achiral stationary phase. Before the chromatography, the drug was isolated from the plasma matrix by solid-phase extraction. For 5-fluorouracil, chromatography was performed on a classical RP-18 column after extraction from the plasma by liquid-liquid extraction. Both methods were validated and applied to the analysis of patients' samples.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D002021 Buffers A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. Buffer
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
March 1997, Analytical biochemistry,
C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
January 1992, Journal of chromatography,
C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
April 1988, Journal of chromatography,
C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
March 1997, Se pu = Chinese journal of chromatography,
C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
April 2003, Journal of chromatography. A,
C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
October 1992, Journal of chromatography,
C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
December 1999, Journal of chromatography. B, Biomedical sciences and applications,
C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
October 1982, Journal of chromatography,
C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
March 2017, Acta poloniae pharmaceutica,
C Vandenbosch, and S van Belle, and M de Smet, and G Taton, and V Bruynseels, and G Vandenhoven, and D L Massart
April 2001, Biomedical chromatography : BMC,
Copied contents to your clipboard!